📰 Michael Lampe News
Page 2 - Michael Lampe News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Michael Lampe. Real-time updates on events, politics, business and more.
April 6, 2023
CAMBRIDGE, Mass., April 06, 2023 -- Foghorn® Therapeutics Inc. , a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases by correcting... | April 6, 2023
April 6, 2023
CAMBRIDGE, Mass., April 06, 2023 -- Foghorn® Therapeutics Inc. , a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases by correcting abnormal... | June 20, 2023
August 9, 2022
09.08.2022 - - FHD-286 dose escalation Phase 1 study in metastatic uveal melanoma continues to progress per protocol; working to resolve partial clinical hold in AML and MDS - On track to report initial Phase 1 clinical data for FHD-609 in synovial ...
August 9, 2022
Foghorn Therapeutics Provides Second Quarter 2022 Financial and Corporate Update -FHD-286 dose escalation Phase 1 study in metastatic uveal melanoma continues... | August 9, 2022
June 9, 2022
DCVC and Magnetic Ventures co-led a $25 million seed financing, with participation from Khosla Ventures, OMERS Ventures, and firstminute Capital, among others Relation Therapeutics, the pioneer of
May 19, 2022
CAMBRIDGE, Mass., May 19, 2022 -- Foghorn® Therapeutics Inc. , a clinical stage biotechnology company pioneering a new class of medicines that modulate gene expression through selectively... | May 19, 2022
February 14, 2022
On Wednesday, a Kern County judge granted a motion to disqualify Michael Lampe from representing the Tulare hospital board over his own strenuous objections.